Pharmicell Co Ltd
KRX:005690

Watchlist Manager
Pharmicell Co Ltd Logo
Pharmicell Co Ltd
KRX:005690
Watchlist
Price: 14 420 KRW -0.76% Market Closed
Market Cap: 865.5B KRW

Operating Margin
Pharmicell Co Ltd

23.3%
Current
9%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
23.3%
=
Operating Profit
21B
/
Revenue
89.9B

Operating Margin Across Competitors

No Stocks Found

Pharmicell Co Ltd
Glance View

Market Cap
865.3B KRW
Industry
Biotechnology

Pharmicell Co., Ltd. is engaged in the development of stem cell based pharmaceuticals and technologies. The company is headquartered in Seoul, Seoul and currently employs 127 full-time employees. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. The company also provides steam cell storage services, and mesenchymal stem cells (MSCs) used for research areas and others. In addition, the Company engages in the fashion business, which provides women’s and men’s apparels under the brand names of Religion and Day. On March 31, 2013, the Company merged with its wholly owned subsidiary, mainly engaged in the manufacture and sale of medicines.

Pharmicell Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
23.3%
=
Operating Profit
21B
/
Revenue
89.9B
What is the Operating Margin of Pharmicell Co Ltd?

Based on Pharmicell Co Ltd's most recent financial statements, the company has Operating Margin of 23.3%.

Back to Top